| Industry | 科学研究和技术服务业 | ||||||||||||||||||||||||
| Company Introduction | 公司的主营业务起始于2007年由谢良志博士创立的神州细胞有限。2016年，义翘有限由神州细胞有限以派生分立方式设立。2016年10月20日，经神州细胞有限股东会审议通过，同意神州细胞有限按分立方案进行存续分立，分立后分别为神州细胞有限和义翘有限。分立后的神州细胞有限注册资本为4,114.56万元，义翘有限注册资本为457.17万元。2016年12月22日，北京市工商行政管理局核发《分立变更证明》，核准办理神州细胞有限变更登记。同日，义翘有限获得了由北京市工商行政管理局核发的《分立设立证明》，并获得新核发的营业执照。公司系由义翘有限整体变更设立的股份有限公司。2020年3月25日，义翘有限召开董事会，同意将义翘有限变更为股份有限公司。2020年3月26日，义翘科技召开了创立大会，全体股东签署了《发起人协议》。2020年3月27日，义翘科技获得了北京市工商行政管理局经济技术开发区分局核准换发的营业执照。 公司是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司，主要业务包括重组蛋白、抗体、基因和培养基等产品，以及重组蛋白、抗体的开发和生物分析检测等服务。 | ||||||||||||||||||||||||
| Main Business | 从事生物试剂研发、生产、销售并提供技术服务 | ||||||||||||||||||||||||
| Legal Representative | 张杰 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 冯涛 | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 致同会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-50911676 | ||||||||||||||||||||||||
| Fax No | 010-50953280 | ||||||||||||||||||||||||
| Website | www.sinobiological.com | ||||||||||||||||||||||||
| ir@sinobiological.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 16/08/2021 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 2.013 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 2.000 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 49.280 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 9.954B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |